MedTrace Logo

Pulmonary Hypertension, Quality of Life and Psychosocial Factors

NCT01380054 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2021-09-05

No results posted yet for this study

Summary

The investigators aim to :

* describe and analyse psychological characteristics, cognitive factors and representations in patients with Pulmonary Hypertension, a rare disease.
* assess the psychological characteristics impact on quality of life, check the association between disease and QoL evolution, and the variability of QoL parameters over severity class changes and follow-up

Conditions

  • Pulmonary Hypertension

Interventions

BEHAVIORAL

Evaluation of quality of life

-Psychological interviews-Questionaires : HAD, STAI, CHIP, MHLC, WCC, SSQ scales-Quality of life : SF-36

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Bourdin Arnaud, MD, PhD · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2016-05-20
Completion
2016-05-20

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01380054 on ClinicalTrials.gov